"I love Cell Therapy Manufacturing and Process Development"

2022-10-05 04:56:03

LOG IN Follow Us: HomeAbout UsOur PeopleOur FacilitiesProcess Development & InnovationCell Processing and ManufacturingQuality Assurance / Quality ControlTraining LabEquipmentOur ServicesClinical Scale ManufacturingProcess Development & ValidationRegulatory FacilitationBusiness Development ServicesEducation and TrainingNewsroomEventsResourcesClinical Trial and Beta TestingCTGT Translational ResearchcGMP GuidelinesLearning PortalDownloadsCareerContact Us Accessibility, to Cellular Therapeutics Learn More Commitment, to training, quality and standards Learn More Teamwork, in fostering a vibrant ecosystem Learn More Reliability, in our people and of our leaders Learn More Innovative, in promoting research and development Learn More Service Excellence, to our partners and our patients Learn More ABOUT US WE ARE ACTRIS The Advanced Cell Therapy and Research Institute, Singapore (ACTRIS), was established on 20 April 2020 to meet the increasing demand of cellular therapy process development and product manufacturing to enable clinical utility.ACTRIS’s vision is to be the national and regional Centre of Excellence for facilitating discovery, process development and manufacturing of cellular-based therapeutics across the broad spectrum of immunotherapy and regenerative medicine encompassing investigational and approved cellular therapeutics. READ MORE OUR SERVICES ACTRIS provide value-added services such as workforce training, business strategy, regulatory facilitation and cell manufacturing and process development. READ MORE OUR FACILITIES Advanced Cell Therapy and Research Institute, Singapore (“ACTRIS”) at National Cancer Center, Singapore (“NCCS”) Building will comprise of a current Good Manufacturing Practice (“cGMP”) Facility and a Good Tissue Practice (“GTP”) Facility that will serve to meet the increasing demand for cell, tissue and gene therapy (CTGT) products process development and manufacturing as well as related translational research in Singapore and the surrounding ASEAN region. READ MORE EDUCATION & TRAINING ACTRIS Education and Training is set up to support ACTRIS’ in one of the three aspects of its mission, that is, to equip those involved in various aspects of cellular-based therapy’s value chain with skills and knowledge. Cell therapy training is critical in stepping up cell, tissue and gene therapy work in Singapore and region and we are able to leverage on our internal expertise in process development & validation, product characterization, clinical trials, clinical care and clinical cell manufacturing for training and education. READ MORE Business Development Services ACTRIS provide business service support to researcher and new start-up company to help them to accelerate their project from process development up to commercialisation stage with the support from our team of in-house expert. We offer customised consultation and solution to identify gaps and mitigate the risks and challenges which hinder the product progress towards commercialisation, by looking into methodology which de-risk early phase development and accelerate the product development times. READ MORE NEWSROOM Launch of a New National Consortium to Advance Clinical Research and Innovation for Singapore Launch of a New National Consortium to Advance Clinical Research and Innovation for Singapore A new national consortium – the Consortium for Clinical Research and Innovation, Singapore (CRIS) – has been officially launched by the Minister for Health Mr Ong Ye Kung on 6 April 2022  CRIS brings together five key national R&D, clinical translation […] READ MORE CRIS Scientific Symposium 2022 – Advancing Clinical Research and Innovation in Singapore Join us at the inaugural scientific symposium organised by the Consortium for Clinical Research and Innovation, Singapore (CRIS) on Wed 6 April 2022. Delve into the future of clinical research and healthcare innovation with topics such as Singapore’s National Precision Medicine strategy, leading-edge cell therapy technologies, how to enable sustainability in cancer research, and catalyse clinical […] READ MORE [ANNOUNCEMENT] Appointment of CEO (CRIS) and ED (SCRI) About the Consortium for Clinical Research and Innovation Singapore (CRIS) The Consortium for Clinical Research and Innovation Singapore (CRIS), a wholly owned subsidiary of MOH Holdings, has been established in 2020 with the goal of strengthening synergies and promulgating strategies for national-level clinical research and translation programmes that are under the stewardship of the Ministry of Health (MOH). […] READ MORE VIEW ALL NEWS SITEMAP HomeNewsroomAbout UsEventsOur PeopleResourcesOur FacilitiesCareerOur ServicesContact Us OUR SERVICES Clinical Scale ManufacturingProcess Development & ValidationRegulatory FacilitationBusiness Development ServicesEducation and Training HELPFUL LINKS Terms & ConditionsPrivacy Policy FOLLOW US Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) is a business unit of the Consortium for Clinical Research and Innovation Singapore (CRIS) Copyright © 2022 ACTRIS. All Rights Reserved.